Free Trial

MBX Biosciences (MBX) Institutional Ownership

MBX Biosciences logo
$9.89 -0.65 (-6.17%)
Closing price 01/17/2025 04:00 PM Eastern
Extended Trading
$10.06 +0.17 (+1.72%)
As of 09:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for MBX Biosciences (NYSE:MBX)

Number of
Institutional Buyers
(last 12 months)
15
Total
Institutional Inflows
(last 12 months)
$384.09M
Number of
Institutional Sellers
(last 12 months)
0
Get MBX Insider Trade Alerts

Want to know when executives and insiders are buying or selling MBX Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MBX Institutional Buying and Selling by Quarter

MBX Biosciences Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/27/2024Franklin Resources Inc.450,000$11.69M0.0%N/A1.347%
11/19/2024Barclays PLC16,400$426K0.0%N/A0.049%
11/18/2024Teachers Retirement System of The State of Kentucky26,708$694K0.0%N/A0.080%
11/16/2024Geode Capital Management LLC22,269$579K0.0%N/A0.067%
11/15/2024Frazier Life Sciences Management L.P.5,985,347$155.50M6.2%N/A17.909%
11/15/2024Barclays PLC16,400$426K0.0%N/A0.049%
11/15/2024Jane Street Group LLC26,570$690K0.0%N/A0.080%
11/15/2024Wellington Management Group LLP2,937,853$74.26M0.0%N/A8.791%
11/15/2024Soros Fund Management LLC30,000$779K0.0%N/A0.090%
11/15/2024RA Capital Management L.P.1,511,334$39.26M0.5%N/A4.522%
11/15/2024Point72 DIFC Ltd24,011$624K0.0%N/A0.072%
11/15/2024Point72 Asset Management L.P.15,600$405K0.0%N/A0.047%
11/15/2024Maven Securities LTD50,000$1.30M0.0%N/A0.150%
11/15/2024Point72 Asia Singapore Pte. Ltd.10,706$278K0.1%N/A0.032%
11/14/2024NEA Management Company LLC3,614,486$93.90M5.1%N/A10.816%
11/13/2024The Manufacturers Life Insurance Company46,194$1.20M0.0%N/A0.138%
(Data available from 1/1/2016 forward)

MBX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MBX shares?

During the previous two years, 15 institutional investors and hedge funds held shares of MBX Biosciences. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($155.50M), NEA Management Company LLC ($93.90M), Wellington Management Group LLP ($74.26M), RA Capital Management L.P. ($39.26M), Franklin Resources Inc. ($11.69M), Maven Securities LTD ($1.30M), and The Manufacturers Life Insurance Company ($1.20M).Learn more on MBX's institutional investors.

Which institutional investors have been buying MBX Biosciences stock?

Of the 15 institutional investors that purchased MBX Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($5.99M), NEA Management Company LLC ($3.61M), Wellington Management Group LLP ($2.94M), RA Capital Management L.P. ($1.51M), Franklin Resources Inc. ($450K), Maven Securities LTD ($50K), and The Manufacturers Life Insurance Company ($46.19K).

How much institutional buying is happening at MBX Biosciences?

Institutional investors have bought a total of 14,783,878 shares in the last 24 months. This purchase volume represents approximately $384.09M in transactions.



This page (NYSE:MBX) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners